Companies / Germany
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Firms Slam Fresh Price Cut Threats
September 2006 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Smaller German drugmakers have opposed any further government moves to cut medicines costs, following deep reductions in generic drug prices in recent months. Germany's mid-sized pharmaceutical companies have witnessed a frenzy of M&A activity in recent weeks, at a time when the so-called Economic Optimization of Pharmaceutical Care Act (AVWG) is introducing harsh cost cuts..